CA2451728A1 — Zonisamide use in headache
Assigned to Eisai Inc · Expires 2003-01-09 · 23y expired
What this patent protects
The present invention is directed to a method of treating headache, includin g migraine. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of zonisamide. The methods of the present invention are useful in relieving headach…
USPTO Abstract
The present invention is directed to a method of treating headache, includin g migraine. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of zonisamide. The methods of the present invention are useful in relieving headache. The compounds of the present method can also be used in conjunction with other therapeutic agents commonly used to treat headache thus enhancing the therapeutic effect of reducing headache.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.